Skip to main content
Enkhtsetseg Purev, MD, Oncology, Aurora, CO, UCHealth Memorial Hospital

EnkhtsetsegPurevMD

Oncology Aurora, CO

Hematologic Oncology

Physician

Dr. Purev is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Purev's full profile

Already have an account?

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2012 - 2015
  • Cooper Medical School of Rowan University/Cooper University Hospital
    Cooper Medical School of Rowan University/Cooper University HospitalResidency, Internal Medicine, 2009 - 2012

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2019 - 2025
  • CO State Medical License
    CO State Medical License 2015 - 2021
  • MD State Medical License
    MD State Medical License 2011 - 2015
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Venetoclax with Azacitidine Disrupts Energy Metabolism and Targets Leukemia Stem Cells in Patients with Acute Myeloid Leukemia  
    Daniel A Pollyea, Jonathan A Gutman, Enkhtsetseg Purev, Clayton Smith, Nature
  • Article Subversion of Systemic Glucose Metabolism as a Mechanism to Support the Growth of Leukemia Cells  
    Natalie J Serkova, Daniel A Pollyea, Enkhtsetseg Purev, ScienceDirect

Abstracts/Posters

  • Interim Results from the Phase I Deplethink Trial Evaluating the Infusion of a NKG2D CAR T-Cell Therapy Post a Non-Myeloablative Conditioning in Relapse or Refractory ...
    Enkhtsetseg Purev, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Venetoclax and Azacitidine for Older Newly Diagnosed Patients with Acute Myeloid Leukemia: A Single-Institution Pilot Study Using Measurable Residual Disease to Guide ...
    Enkhtsetseg Purev, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Outcomes Following Allogeneic Stem Cell Transplantation for AML in First Completion Remission Are Comparable between MRD Negative Patients and MRD Positive Patients Re...
    Enkhtsetseg Purev, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Hospital Affiliations